We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current VAXX market cap is 8.84M. The company's latest EPS is USD -0.5044 and P/E is -0.22.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 557k | 66k | 0 | 0 |
| Operating Income | -13.66M | -32.28M | -125.08M | -75.98M | -58.29M |
| Net Income | -14.22M | -39.96M | -137.18M | -75.22M | -56.93M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.6M | 50.14M | 166.67M | 106.4M | 44.31M |
| Total Liabilities | 23.29M | 75.04M | 38.05M | 44.22M | 30.9M |
| Total Equity | -48.51M | -87.38M | 128.62M | 62.18M | 13.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.27M | -33.91M | -80.99M | -55.93M | -57.24M |
| Investing | N/A | -1.48M | -1.32M | -54.39M | 28.84M |
| Financing | 11.14M | 66.11M | 196.17M | -167k | -1.14M |
| Market Cap | 8.84M |
| Price to Earnings Ratio | -0.22 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.52 |
| Price to Book Ratio | 0.93 |
| Dividend Yield | - |
| Shares Outstanding | 112.87M |
| Average Volume (1 week) | 261.04k |
| Average Volume (1 Month) | 1.09M |
| 52 Week Change | -2.13% |
| 52 Week High | 0.119 |
| 52 Week Low | 0.0453 |
| Spread (Intraday) | 0.01 (10.47%) |
| Company Name | Vaxxinity Inc (PK) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://vaxxinity.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
